Case File
efta-01741496DOJ Data Set 10OtherEFTA01741496
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-01741496
Pages
5
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
Subject: WAM Global Macro Program - September 2016 U ate revised]
From:
Whitman Asset Management (WAM)
To:
Jeffrey Epstein <jeevacation©grnail.corn>
Sent
Thursday, October 20, 2016 4:03:21 PM
Whitman Asset Management - September 2016 Performance Update
View this email in your browser
WAM Global Macro Program (2X and 1X)
September 2016 Update
Noteworthy:
• Market and Strategy commentary now available via links below
• WAM positive returns diverge from SG CTA Index for a 2nd
consecutive month
• WAM increases proprietary capital allocation by 50% in September
2X
Net Returns*
September: +2.30%
2016 YTD: +4.06%
AROR: +12.73%
lx
Net Returns*
EFTA_R1_00031548
EFTA01741496
September: +1.31%
2016 YTD: +1.10%
AROR: +5.97%
2X
Risk Metrics
Sharpe: 1.96
Volatility: 6.48%
Max DD: 2.02%
lx
Risk Metrics
Sharpe: 1.52
Volatility: 3.92%
Max DD: 1.40%
2X
Nominal AUM
Program: $12.5M
EFTA_R1_00031549
EFTA01741497
Firm: $32.5M
Proprietary: $7.5M
lx
Nominal AUM
Program: $25M
Firm: $32.5M
Proprietary: $7.5M
Download 2X Performance & Commentary
Download 1X Performance & Commentary
PAST PERFORMANCE IS NOT NECESSARILY INDICATIVE OF FUTURE RESULTS
* Please see Performance Notes below
Contact:
Jeffrey Roy
Whitman Asset Management
Performance Notes: The performance tables and charts herein contain the
actual results of WAM proprietary accounts from Oct 2014 - Nov 2015 and client
accounts from Dec 2015 forward. For the standard (1X) Program, gross returns
EFTA_R1_00031550
EFTA01741498
have been adjusted by 2% management and 20% incentive fees. For the 2X
Program, gross returns have been pro-forma adjusted by 0% management and
35% incentive fees and for approximately twice the leverage of the standard
Program. As such, reported 2X Program AUM is 1/2 the AUM of the standard
program.
Disclaimers: This message w/attachments is intended solely for the use of the
intended recipient(s) and may contain information that is privileged, confidential
or proprietary. If you are not an intended recipient, please notify the sender, and
then please delete and destroy all copies and attachments, and be advised that
any review or dissemination of, or the taking of any action in reliance on, the
information contained in or attached to this message is prohibited.
The WAM Global Macro Program is available only to "qualified eligible persons" as
defined in CFTC Rule 4.7. Nothing set forth herein shall constitute an offer to sell
any securities or constitute a solicitation of an offer to purchase any securities.
Any such offer to sell or solicitation of an offer to purchase shall be made only by
formal offering documents. Each potential investor should read the formal
offering documents in their entirety and should carefully consider the risks,
warnings and disclosures. The information contained in this document is strictly
confidential and supplied with the understanding that it will be held in confidence
and not copied or disclosed to third parties without prior consent of Whitman
Asset Management LLC.
If this message contains estimated performance, the information has been
obtained from or based upon sources believed by the sender to be reliable, but
the sender does not represent or warrant its accuracy or completeness and is not
responsible for losses or damages arising out of errors and/or omissions.
EFTA_R1_00031551
EFTA01741499
Copyright O2016 Whitman Asset Management. All rights reserved.
Our mailing address is:
Whitman Asset Management
401 N. Michigan Avenue
Suite 1910
Chicago. IL 60611
Add us to your address book
Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list
EFTA_R1_00031552
EFTA01741500
Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.